| Darren Elenburg Dpm Pc | |
|
609 W Memorial Rd, Oklahoma City, OK 73114-2006 | |
| (405) 418-2676 | |
| (405) 418-2677 |
| Full Name | Darren Elenburg Dpm Pc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 609 W Memorial Rd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558567537 | NPI | - | NPPES |
| 200119580A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 226 (Oklahoma) | Primary |
| Provider Name | Darren Elenburg |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1548269459 PECOS PAC ID: 8820189574 Enrollment ID: I20070809000243 |
News Archive
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
BankAtlantic, Florida's Most Convenient Bank, announced today that it has partnered with Tenet South Florida Hospitals to provide outreach events designed to improve the health of the local community. The partnership involves branches and hospitals from Miami-Dade to Martin County, and includes events such as screenings and lectures.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.
› Verified 6 days ago
| Provider Name | Chad Michael Knight |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1174057624 PECOS PAC ID: 5890061253 Enrollment ID: I20200713000163 |
News Archive
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
BankAtlantic, Florida's Most Convenient Bank, announced today that it has partnered with Tenet South Florida Hospitals to provide outreach events designed to improve the health of the local community. The partnership involves branches and hospitals from Miami-Dade to Martin County, and includes events such as screenings and lectures.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.
› Verified 6 days ago
| Provider Name | N Bryce Andrew Corlee |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1295391175 PECOS PAC ID: 0244661882 Enrollment ID: I20230619000681 |
News Archive
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
BankAtlantic, Florida's Most Convenient Bank, announced today that it has partnered with Tenet South Florida Hospitals to provide outreach events designed to improve the health of the local community. The partnership involves branches and hospitals from Miami-Dade to Martin County, and includes events such as screenings and lectures.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darren Elenburg Dpm Pc 609 W Memorial Rd, Oklahoma City, OK 73114-2006 Ph: (405) 418-2676 | Darren Elenburg Dpm Pc 609 W Memorial Rd, Oklahoma City, OK 73114-2006 Ph: (405) 418-2676 |
News Archive
Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met.
BankAtlantic, Florida's Most Convenient Bank, announced today that it has partnered with Tenet South Florida Hospitals to provide outreach events designed to improve the health of the local community. The partnership involves branches and hospitals from Miami-Dade to Martin County, and includes events such as screenings and lectures.
ARIAD Pharmaceuticals, Inc. today announced that its investigational pan-BCR-ABL inhibitor, AP24534, has been granted orphan drug designation by both the U. S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). In the U.S., the orphan designation of AP24534 is for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and in the E.U., its orphan designation is for CML and acute lymphoblastic leukemia.
The outbreak of mumps which is currently rife in parts of Canada has prompted Health officials to make 40,000 doses of a mumps booster available to health workers across Nova Scotia.
› Verified 6 days ago
Dr. Terry M Nayfa, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3612 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-947-5492 Fax: 405-947-5532 | |
Timothy D Thomas, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. John Andrew Maupin Jr., DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 705 Nw 57th St, Oklahoma City, OK 73118 Phone: 405-550-0060 | |
David G. Wade Dpm Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3330 Nw 56th St, #600, Oklahoma City, OK 73112 Phone: 405-947-8041 | |
Alaina Janae Jones, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-418-4500 Fax: 405-418-4501 | |
Dr. Nicholas B Plants, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9315 S. Pennsylvania Ave, Suite A, Oklahoma City, OK 73159 Phone: 405-691-9004 Fax: 405-691-9003 | |
Peter Quoc Le Podiatrist Medicare: Medicare Enrolled Practice Location: 2201 N Meridian Ave, Oklahoma City, OK 73107 Phone: 405-943-9820 Fax: 405-947-6908 |